Dry eye

There is a high risk of ocular complications in patients with cancer undergoing immune checkpoint inhibitor (ICI) therapy, with up to half of some specific patient populations experiencing ophthalmic immune-related adverse events (OirAEs), according to data from a retrospective IRIS Registry study presented at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program.

Amongst the 3123 patients who received anti-CTLA-4, anti-PD-1, or anti-PD-L1 therapy, 111 developed…


View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Conference Roundup

  1. Jun 01, 2020

High risk of ocular complications in patients with cancer undergoing immune checkpoint therapy

There is a high risk of ocular complications in patients with cancer undergoing immune checkpoint inhibitor (ICI) therapy, with up to half of some specific patient populations experiencing ophthalmic immune-related adverse events (OirAEs), according to data from a

Journal Scan

  1. May 21, 2020

Vitamin D Deficiency Worsens Symptoms of Dry Eye Disease

In this systematic review and meta-analysis, 10 clinical studies were identified that evaluated the association between vitamin D levels and dry eye. Mean serum vitamin D levels were found to be 3.99 ng/ml lower in patients with dry eye than in control patients.…